Table 2.
Baseline characteristics of the patients with sEMG.
| Characteristics | Experimental group (n = 17) | Control group (n = 13) | p value |
|---|---|---|---|
| Age (years) | 55.31 ± 11.47 | 60.54 ± 10.72 | 0.437 |
| Onset time (months) | 3.00 ± 4.00 | 3.00 ± 3.00 | 0.175 |
| Male/female | 14/3 | 12/1 | 0.355 |
| Injury site (left/right) | 7/10 | 7/6 | 0.713 |
| FMA-LE | 19.00 ± 6.29 | 18.69 ± 6.56 | 0.443 |
| FAC | 3.00 ± 1.00 | 3.00 ± 0.00 | 0.087 |
| MAS | 1.00 ± 1.00 | 1.00 ± 1.00 | 0.350 |
| CCI knee | 0.40 ± 0.11 | 0.38 ± 0.10 | 0.818 |
| CCI ankle | 0.34 ± 0.23 | 0.30 ± 0.17 | 0.691 |
Values denote means ± SD unless specified otherwise. The skewed distributed variables (onset time, FAC, and MAS) were presented as median ± interquartile range (IQR).